FDA Inspection 1108056 — ImpactLife
The FDA completed an inspection of ImpactLife on September 18, 2019 in Moline, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 18, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Moline, IL (United States)